title: Determining the cost of genital warts: a study from Ireland.
abstract: OBJECTIVE
  To determine the average cost of a case of genital warts, for both males and females, with a view to informing the current debate as to which Human papillomavirus vaccine would have maximum cost-effectiveness in the Irish population.
  
  
  METHODS
  Contact time between patients and healthcare professionals was prospectively measured at five genitourinary medicine clinics in the south-west of Ireland, over a period of 3 weeks. By identifying all those with genital warts, it was possible to calculate the proportion of total time taken by patients with this condition, and from this to calculate a cost per incident case, by gender.
  
  
  RESULTS
  A total of 25.5% of attendances were for genital warts, and these patients used 26.2% of total clinic time (CI 25.4 to 27.0%). The average cost calculated for genital warts was 335 euros per incident case, and by gender 300 euros per male case and 366 euros per female case.
  
  
  CONCLUSIONS
  There are considerable costs associated with the treatment of genital warts, with female cases representing a higher cost than males. By vaccinating with the quadrivalent HPV vaccine, there are significant savings to be made.
authors.affiliation: Department of Public Health, HSE-West, Limerick, Ireland. anne.dee@oceanfree.net
authors.forename: A
authors.initials: A
authors.lastname: Dee
authors.forename: F
authors.initials: F
authors.lastname: Howell
authors.forename: C
authors.initials: C
authors.lastname: O'Connor
authors.forename: S
authors.initials: S
authors.lastname: Cremin
authors.forename: K
authors.initials: K
authors.lastname: Hunter
mesh_terms: D000553:Ambulatory Care / Q000191:economics*; D003218:Condylomata Acuminata / Q000191:economics*; D005260:Female; D017048:Health Care Costs; D006801:Humans; D007494:Ireland; D008297:Male; D030361:Papillomavirus Infections / Q000191:economics* / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000191:economics; D011446:Prospective Studies
chemical_list: D053918:Papillomavirus Vaccines